Vol 9, No 1 (February 25, 2020) - Translational Lung Cancer Research

Editorial

Targeting the tyrosine kinase inhibitor-resistant mutant EGFR pathway in lung cancer without targeting EGFR?

Jacques De Greve, Philippe Giron

PDF Pages: 1-3 Full Text (1424) Open Access

Patient-reported outcome measures in definitive chemoradiation for non-small cell lung cancer

Khinh Ranh Voong, Josephine L. Feliciano

PDF Pages: 4-7 Full Text (1716) Open Access

What’s in a (tumor) cavity?

Michael J. McKay

PDF Pages: 8-9 Full Text (1205) Open Access

Original Article

Low-dose CT lung cancer screening in never-smokers and smokers: results of an eight-year observational study

Ryutaro Kakinuma, Yukio Muramatsu, Hisao Asamura, Shun-ichi Watanabe, Masahiko Kusumoto, Takaaki Tsuchida, Masahiro Kaneko, Koji Tsuta, Akiko Miyagi Maeshima, Genichiro Ishii, Kanji Nagai, Taiki Yamaji, Takahisa Matsuda, Noriyuki Moriyama

PDF Pages: 10-22 Full Text (6795) Peer Review File Open Access

Comparison of autofluorescence and white-light bronchoscopies performed with the Evis Lucera Spectrum for the detection of bronchial cancers: a meta-analysis

Shuangshuang Sun, Yang Yang, Meizi Chen, Li Wang, Hangcheng Pan, Xiuwei Zhang, Georges Wagnieres, Yousser Mohammad, Esther Barreiro, Giovanni Pirozzolo, P. James Villeneuve, Ping Zhan, Bing Wan, written on behalf of the AME Lung Cancer Collaborative Group

PDF Pages: 23-32 Full Text (1863) Open Access

Extent of resection and lymph node evaluation in early stage metachronous second primary lung cancer: a population-based study

Rusi Zhang, Gongming Wang, Yongbin Lin, Yingsheng Wen, Zirui Huang, Xuewen Zhang, Xiangyang Yu, Weidong Wang, Kexing Xi, Robert J. Cerfolio, Xavier Benoit D’Journo, Kurt Ruetzler, Lieven Depypere, Pier Luigi Filosso, Lanjun Zhang, written on behalf of AME Thoracic Surgery Collaborative Group

PDF Pages: 33-44 Full Text (2115) Open Access

Neutrophil or platelet-to-lymphocyte ratios in blood are associated with poor prognosis of pulmonary large cell neuroendocrine carcinoma

Minxing Shi, Wencheng Zhao, Fei Zhou, Hao Chen, Liang Tang, Bo Su, Jie Zhang

PDF Pages: 45-54 Full Text (2206) Open Access

A detailed smoking history and determination of MYC status predict response to checkpoint inhibitors in advanced non-small cell lung cancer

Michelle Chiu, Mary Beth Lipka, Priyanka Bhateja, Pingfu Fu, Afshin Dowlati

PDF Pages: 55-60 Full Text (2243) Open Access

Targeted sequencing analysis of cell-free DNA from metastatic non-small-cell lung cancer patients: clinical and biological implications

Raffaella Pasquale, Laura Forgione, Cristin Roma, Francesca Fenizia, Francesca Bergantino, Anna M. Rachiglio, Antonella De Luca, Marianna Gallo, Monica R. Maiello, Giuliano Palumbo, Alessandro Morabito, Rosa Azzaro, Nicola Normanno

PDF Pages: 61-70 Full Text (2902) Open Access

Tumor mutation burden derived from small next generation sequencing targeted gene panel as an initial screening method

Yuan Tang, Yuli Li, Weiya Wang, Analyn Lizaso, Ting Hou, Lili Jiang, Meijuan Huang

PDF Pages: 71-81 Full Text (3694) Open Access

The prognostic effect of TTF-1 expression in the Chinese population of patients with advanced lung adenocarcinomas

Xueying Li, Ling Yin, Yamei Zhao, Man He, Qi Qi, Yang Sun, Hongmei Li, Matthew Evison, written on behalf of the AME Lung Cancer Collaborative Group

PDF Pages: 82-89 Full Text (1922) Open Access

Prognostic factors of lung cancer in lymphoma survivors (the LuCiLyS study)

Alfonso Fiorelli, Antonio D’Andrilli, Annalisa Carlucci, Giovanni Vicidomini, Domenico Loizzi, Nicoletta Pia Ardò, Rita Daniela Marasco, Luigi Ventura, Luca Ampollini, Paolo Carbognani, Giovanni Bocchialini, Filippo Lococo, Massimiliano Paci, Teresa Severina Di Stefano, Francesco Ardissone, Matteo Gagliasso, Paolo Mendogni, Lorenzo Rosso, Alessandra Mazzucco, Camilla Vanni, Beatrice Trabalza Marinucci, Rossella Potenza, Alberto Matricardi, Mark Ragusa, Valentina Tassi, Marco Anile, Camilla Poggi, Nicola Serra, Antonello Sica, Mario Nosotti, Francesco Sollitto, Federico Venuta, Erino Angelo Rendina, Francesco Puma, Mario Santini, The LuCiLyS study group

PDF Pages: 90-102 Full Text (3699) Open Access

Endocrine adverse events related to immune-oncology agents: retrospective experience of a single institution

Sofia España, Alejandra Pérez Montes de Oca, Montserrat Marques-Pamies, Marc Cucurull, Marta Domenech, José María Velarde, Isabel Salinas, Teresa Moran, Olatz Etxaniz

PDF Pages: 103-110 Full Text (1893) Open Access

Review Article

Frontiers of ctDNA, targeted therapies, and immunotherapy in non-small-cell lung cancer

Chennianci Zhu, Weihao Zhuang, Limin Chen, Wenyu Yang, Wen-Bin Ou

PDF Pages: 111-138 Full Text (4985) Open Access

Case Report

Dynamic changes of acquired T790M mutation and small cell lung cancer transformation in a patient with EGFR-mutant adenocarcinoma after first- and third-generation EGFR-TKIs: a case report

Shuxiang Ma, Zhen He, Hongyong Fu, Lili Wang, Xuan Wu, Zhe Zhang, Qiming Wang

PDF Pages: 139-143 Full Text (2715) Open Access

Rechallenge with erlotinib in osimertinib-resistant lung adenocarcinoma mediated by driver gene loss: a case report

Lingli Liu, Analyn Lizaso, Xinru Mao, Nong Yang, Yongchang Zhang

PDF Pages: 144-147 Full Text (4329) Open Access

Editorial Commentary

KEYNOTE-407: changing the way we treat stage IV squamous non-small cell lung cancer

Jose M. Pacheco

PDF Pages: 148-153 Full Text (4960) Open Access

Treatment failure patterns of adjuvant gefitinib therapy and minimal residual disease detection in resected EGFR-mutant non-small cell lung cancer: author’s reply

Song-Tao Xu, Jia-Cheng Yin, Jun-Jie Xi, Qun Wang, Wen-Zhao Zhong, Yi-Long Wu

PDF Pages: 160-162 Full Text (1767) Open Access

Vol 9, No 1 (February 25, 2020): Translational Lung Cancer Research